Diagnosis and surgical treatment of intrahepatic hepatolithiasis associated cholangiocarcinoma

Asian Journal of Surgery

Volumn 32, Issue 1, 2009, Pages 1-6

  Han, Shao Liang ^a,b   Zhou, Hong Zhong ^a   Cheng, Jun ^a   Lan, Sheng Hong ^a   Zhang, Pei Chen ^a   Chen, Zhe Jing ^a   Zeng, Qi Qiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cholelithiasis; Explosive decompression; Intrahepatic cholangiocellular carcinoma; Liver neoplasm

Indexed keywords

EID: 62949084087     PISSN: 10159584     EISSN: 02193108     Source Type: Journal    
DOI: 10.1016/S1015-9584(09)60001-4     Document Type: Article

References (39)

1. Chen MF. Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol 1999;14:1144-9.
2. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathological features and results of surgical treatment. Ann Surg 1990;211:277-87.
3. Koga A, Ichimiya H, Yamaguchi K, et al. Hepatolithiasis associated with cholangiocarcinoma. Possible etiologic significance. Cancer 1985;55:2826-9.
4. Altaee MY, Johnson PJ, Farrant JM, et al. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer 1991;68:2051-5.
5. Zhou YM, Yin ZF, Yang JM, et al. Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol 2008;14:632-5.
6. Ben-Menachem T. Risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol 2007;19:615-7.
7. Jan YY, Chen HM, Chen MF. Malignancy in choledochal cysts. Hepatogastroenterology 2002;49:100-3.
8. Imazu M, Iwai N, Tokiwa K, et al. Factors of biliary carcinogenesis in choledochal cysts. Eur J Pediatr Surg 2001;l1:24-7.
9. Chapman RW. Risk factors for biliary tract carcinogenesis. Ann Oncol 1999;10(Suppl 4):308-11.
10. Sato M, Watanabe Y, Ueda S, et al. Intrahepatic cholangiocarcinoma associated with hepatolithiasis. Hepatogastroenterology 1998;45:137-44.
11. Chen MF, Jan YY, Jeng LB, et al. Intrahepatic cholangiocarcinoma in Taiwan. J Hepatobiliary Pancreat Surg 1999;6:136-41.
12. Tischoff I, Tannapfel A. Hepatocellular carcinoma and cholangiocarcinoma-different prognosis, pathogenesis and therapy. Zentralbl Cbir 2007;132:300-5. [In German with English abstract]
13. Shirabe K, Shimada M, Harimoto N, et al. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 2002;131:S159-64.
14. Chen MF, Jan YY, Hwang TL, et al. Impact of concomitant hepatolithiasis on patients with peripheral cholangiocarcinoma. Dig Dis Sci 2000;45:312-6.
15. Hanazaki K, Kajikawa S, Shimozawa N, et al. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology 2002;49: 311-6.
16. Chu KM, Lo CM, Liu CL, et al. Malignancy associated with hepatolithiasis. Hepatogastroenterology 1997;44:352-7.
17. Lei HJ, Chau GY, Lui WY, et al. Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma. J Am Coll Surg 2006;203:426-5.
18. Hadjis NS, Adam A, Gibson R, et al. Nonoperative approach to hilar cancer determined by the atrophy-hypertrophy complex. Am J Surg 1989;157:395-9.
19. Suh KS, Roh HR, Koh YT, et al. Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology 2000;31:12-7.
20. Yeh TS, Tseng JH, Chen TC, et al. Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions. Hepatology 2005;42:657-64.
21. Lazaridis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005;128:1655-67.
22. MagnaniJL, Steplewski Z, Koprowski H, et al. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res 1983;43:5489-92.
23. Kim HJ, Kim JS, Kang CD, et al. Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma. Korean J Gastroenterol 2005;45:52-9. [In Korean]
24. Kuroki T, Tajima Y, Kanematsu T. Hepatolithiasis and intrahepatic cholangiocarcinoma: carcinogenesis based on molecular mechanisms. J Hepatobiliary Pancreat Surg 2005;12:463-6.
25. Kinjo N, Shimada M, Maeda T, et al. Preoperatively undiagnosable intrahepatic bile duct dilatation contains early-stage intrahepatic cholangiocarcinoma. Hepatogastroenterology 2005; 52:1368-71.
26. Kim YT, Byun JS, Kim J, et al. Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis. Hepatogastroenterology 2003;50:8-12.
27. Patel AH, Harnois DM, Klee GG, et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000;95:204-7.
28. Kawarada Y, Yamagiwa K, Das BC. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocatcinoma. Am J Surg 2002;183:679-85.
29. Kawarada Y, Mizumoto R. Diagnosis and treatment of cholangiocellular carcinoma of the liver. Hepatogastroenterology 1990; 37:176-81.
30. Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002;89:1525-31.
31. Shiraishi M, Hiroyasu S, Nagahama M, et al. Characteristics of hepatocellular carcinoma in patients with negative virus markers: clinicopathologic study of resected tumours. World J Surg 1999;23:301-5.
32. Chen Y, Li H. Imaging findings of intrahepatic peripheral cholangiocarcinoma. Chin J Oncol 2000;22:318-20. [In Chinese with English abstract]
33. Han SL, Wang HP, Xu LB, et al. Diagnosis and surgical treatment of peripheral intrahepatic cholangiocarcinoma. Chin J Surg 2001;39:590-4. [In Chinese]
34. Yoshida Y, Imai Y, Murakami T, et al. Intrahepatic cholangiocarcinoma with marked hypervascularity. Abdom Imaging 1999; 24:66-8.
35. Yalcin S. Diagnosis and management of cholangiocarcinomas: a comprehensive review. Hepatogastroenterology 2004;51:43-50.
36. Jan YY, Yeh CN, Yeh TS, et al. Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: rwo decades of experience at Chang Gung Memorial Hospiral. World J Gastroenterol 2005;11:1779-84.
37. Harrison LE, Fong Y, Klimstra DS, et al. Surgical treatment of 32 patients with peripheral inttahepatic cholangiocarcinoma. Br J Surg 1998;85:1068-70.
38. Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002;89:1525-31.
39. Sandhu DS, Roberts LR Diagnosis and management of cholangiocarcinoma. Curr Gastroenterol Rep 2008;10:43-52.